Purpose: Quintiles Transnational helps to improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Quintiles also offers medical communications and healthcare consulting services.

Interesting Fact: Quintiles has helped develop or commercialize all of the world’s top 30 best-selling drugs.

Primary Focus: Product development, commercialization, partnering solutions.

Founded: 1982

Top executive: Dennis Gillings, chairman and chief executive officer. He launched Quintiles after coming to North Carolina as a biostatistics professor at the University of North Carolina at Chapel Hill. He worked with pharmaceutical firms as a consultant starting in 1974. Quintiles was incorporated in 1982 with 10 employees.

Ownership: Privately held.

Going Private: Gillings formed a consortium of investors and financial backers to take Quintiles private in September of 2003 in a deal worth $1.3 billion. Other The Gillings-led Pharma Services Holdings group includes One Equity Partners LLC, the private equity arm of Bank One Corporation, Temasek Holdings, Texas Pacific Group, Perseus-Soros BioPharmaceutical Fund (PSBF) and Mitsui & Co.

Employees: 16,000

Employees in Triangle: More than 1,000.

Headquarters: Durham, N.C.

Other locations: Quintiles operates in more than 50 countries.

Revenues: Nearly $2 billion in 2005.

Web site: www.quintiles.com

Sources: Quintiles, WRAL Local Tech Wire news archives.